Andy Lefkarites joined North Bridge Growth Equity in 2014 and is today a Senior Associate. He is actively involved with North Bridge’s investments in Asurint and Ingenious Med. Andy was previously involved with North Bridge’s investment in Valence Health (acquired by Evolent Health).
Prior to joining North Bridge Growth Equity, Andy was an analyst with Houlihan Lokey’s Global Technology Group in San Francisco, where he advised clients on mergers and acquisitions and private placements within the software, internet, technology-enabled services and healthcare IT sectors.
Andy graduated from San Diego State University with a B.S. in Finance.